<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR43">
 <label>43.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Sanchez</surname>
    <given-names>GAM</given-names>
   </name>
   <name>
    <surname>Reinhardt</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Ramsey</surname>
    <given-names>S</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies</article-title>
  <source>J Clin Invest</source>
  <year>2018</year>
  <volume>128</volume>
  <fpage>3041</fpage>
  <lpage>3052</lpage>
  <pub-id pub-id-type="doi">10.1172/JCI98814</pub-id>
  <?supplied-pmid 29649002?>
  <pub-id pub-id-type="pmid">29649002</pub-id>
 </element-citation>
</ref>
